109P Subsequent therapies after progressing to CDK4/6 inhibition (CDK4/6i) in hormone receptor positive/HER2 negative (HR+/HER2-) advanced breast cancer (ABC)
Title:
109P Subsequent therapies after progressing to CDK4/6 inhibition (CDK4/6i) in hormone receptor positive/HER2 negative (HR+/HER2-) advanced breast cancer (ABC)
Author:
Laguna, J.C. Brasó-Maristany, F. Pascual, T. Rodriguez Hernandez, A. Chic, N. Schettini, F. Sanfeliu Torres, E. Gonzalez-Farre, B. Martínez, D. Galván, P. Díez-Guardia, V. Adamo, B. Vidal, M. Guillen Sacoto, M.C. Moreno, R. Prat, A. Muñoz, M. Martínez-Sáez, O.